Gladstone Commercial (GOOD) Renews Lease With Morgan Stanley

Gladstone Commercial Corporation GOOD is witnessing solid demand for its properties from existing as well as new tenants. Recently, the company clinched a five-year lease renewal at its office property in Columbus, OH, with the leading global financial services firm, Morgan Stanley MS

Morgan Stanley's existing tenancy began in 2008, and this lease renewal for 72,301 square feet of the 101,869-square-foot office building at 4343 Easton Commons through Dec 31, 2030 secures GOOD’s cash flows from the property.

Per Ryan Carter, executive vice president for the Midwest and Western Regions for Gladstone Commercial, "Morgan Stanley is an excellent tenant, and we are pleased that our office building meets their requirements for continued operations within the Columbus, Ohio market."

Gladstone Commercial has been witnessing healthy leasing activity, aiding solid occupancy and healthy rental collections. The company collected 100% of cash rents during April, May and June, underscoring the robustness of its tenant base. The strong occupancy rate of 98.5% as of Jun 30, 2024 is a testament to the trust tenants place in the company’s properties and management.

Gladstone Commercial recently sold its two medical office properties in the Atlanta MSA at a cap rate of 5.97%. The properties, which were leased to Northside Hospital, encompassed 26,331 square feet of space. The REIT realized a leveraged internal rate of return of around 13.2% on the properties, which were acquired as part of an eight-property portfolio transaction in 2007. The move came as part of Gladstone Commercial’s capital recycling efforts, allowing the company to redeploy capital into industrial real estate.

GOOD is also focused on expanding on the buyouts of high-quality industrial assets in strong growth corridors leased to tenants with solid credit profiles. In line with this, in May, Gladstone Commercial acquired a 142,125-square-foot industrial manufacturing, distribution and service facility located on 115 acres in Warfordsburg, PA, for $11.7 million at a GAAP capitalization rate of 12.3%.

Shares of this Zacks Rank #3 (Hold) company have risen 16.4% in the past six months, outperforming the industry’s increase of 8.9%.

Zacks Investment Research
Image Source: Zacks Investment Research

Stocks to Consider

Some better-ranked stocks from the REIT sector are Lamar Advertising Company LAMR and Cousins Properties Incorporated CUZ, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for Lamar Advertising’s 2024 FFO per share has moved marginally northward in the past month to $8.08.

The Zacks Consensus Estimate for Cousins Properties’ ongoing-year FFO per share has increased marginally over the past month to $2.66.

Note: Anything related to earnings presented in this write-up represents FFO — a widely used metric to gauge the performance of REITs.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Morgan Stanley (MS) : Free Stock Analysis Report

Lamar Advertising Company (LAMR) : Free Stock Analysis Report

Cousins Properties Incorporated (CUZ) : Free Stock Analysis Report

Gladstone Commercial Corporation (GOOD) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.